#AANAM – SEP‑363856 Shows Promise in Easing Parkinson’s Psychosis
Editor’s note: The Parkinson’s News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April…
Articles by Marisa Wexler, MS
Neurons, Not Nearby Cells, Decide Dopamine Levels, Study Reports
Dopamine-releasing cells in the brain, much like most other hormone-producing cells, have a self-regulating feedback mechanism that controls their activity,…
Project to Explore if Depression Meds Might Ease Dyskinesia Due to L-dopa
A new research project aims to determine whether medications developed to treat depression might be viable candidates for easing some…
Ways of Better Ensuring Good Dental Care in Parkinson’s Reviewed
Regular dental visits and routine tooth brushing with alternating hands are among recommendations for better oral health in people with…
Parkinson’s Mutation Causes Impaired Neuron Growth Throughout Life
Dopamine-producing neurons in the brain grow throughout life, but this growth is hindered by a genetic mutation that is associated…
Research Sheds Light on Iron Accumulation in Patients’ Brains
In Parkinson’s disease, iron accumulates in certain parts of the brain that have characteristic genetic profiles, according to a…
Foundation Hosting Virtual, Contactless Moving Day Events
The Parkinson’s Foundation has announced that this year’s Moving Day walk season will include virtual and contactless events. Moving…
Interim Trial Data Hints at Efficacy of ANVS401
ANVS401, an investigational therapy for neurodegenerative diseases being developed by Annovis Bio, improved the speed and coordination of people…
Trial of Xadago in Treating Levodopa-induced Dyskinesia Planned
Newron Pharmaceuticals and Zambon Pharma agreed to jointly support a potentially pivotal clinical trial of Xadago (safinamide) as a…
Bacteria in Patients’ Guts Show Changes That May Weigh on Disease
People with Parkinson’s disease have substantial changes in the bacteria living in their gut relative to people without this…